IsoPlexis’ groundbreaking intracellular signaling omics application allows users to uniquely analyze signaling cascades of many phosphoproteins directly from each single cell, across thousands of single cells in parallel.
In this on-demand webinar, learn why it’s a critical tool for the characterization of cancer cell resistance pathways and the development of durable targeted therapies to overcome resistance.
Speakers will also discuss the solution’s impact on the fields of immune medicine and oncology, and highlight how it has been used in high-impact studies to predict and target therapeutic resistance in glioblastoma and other metastatic cancers.
Offered Free by: Isoplexis
See All Resources from: Isoplexis